Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment

article

Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41416-018-0211-X
P932PMC publication ID6220113
P698PubMed publication ID30401977

P50authorEllen SchlichtingQ27049894
Riyas VettukattilQ42726521
Tone F. BathenQ61104171
Steinar LundgrenQ65706815
Guro F. GiskeødegårdQ65706869
Hans E FjøsneQ114422032
P2093author name stringHartmut Schäfer
Inger Thune
Hanne Frydenberg
Vidar G Flote
Gro F Bertheussen
Jon Lømo
Erik Wist
Torfinn S Madssen
P2860cites work2-Aminoadipic acid is a biomarker for diabetes riskQ24617890
Understanding the role of the kynurenine pathway in human breast cancer immunobiologyQ26773472
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasisQ26858839
Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubesQ42834541
Metabolic profile, physical activity, and mortality in breast cancer patientsQ43250781
Serum molecular signatures of weight change during early breast cancer chemotherapy.Q43253835
Association between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomesQ43746121
Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsiaQ44434565
Taxane-Induced Peripheral Neurotoxicity.Q45759415
Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humansQ46184312
Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal statusQ47102767
In Vitro lipolysis is associated with whole-body lipid oxidation and weight gain in humansQ47256580
The Effects of Resistance Exercise on Biomarkers of Breast Cancer Prognosis: A Pooled Analysis of Three Randomized TrialsQ47399081
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental healthQ47659177
Tryptophan circuit in fatigue: From blood to brain and cognitionQ47687012
Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failureQ48324317
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.Q50045986
Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study.Q51506465
Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice.Q53248526
Changes in serum lipids and lipoproteins in cancer patients during chemotherapyQ68018409
Effects of oxidative stress on glycerolipid acyl turnover in rat hepatocytesQ73724857
Asymmetric dimethylarginine and carotid atherosclerosis in Type 2 diabetes mellitusQ85388854
NMR-based metabolomics of biofluids in cancerQ88409664
Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsQ28295232
Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammationQ28728589
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsQ29547513
Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin studyQ30829796
Multilevel data analysis of a crossover designed human nutritional intervention studyQ33364501
Multivariate paired data analysis: multilevel PLSDA versus OPLSDA.Q33546330
Weight change during chemotherapy in breast cancer patients: a meta-analysisQ33556428
Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide contentQ33556682
Molecular enzymology of carnitine transfer and transportQ33938860
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular DiseaseQ33940891
Side effects of adjuvant treatment of breast cancerQ34295656
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.Q34358476
Oxidative stress and apoptosis: impact on cancer therapy.Q34642005
Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetesQ35004985
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the hostQ35753611
Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver CellsQ35903199
Specific Metabolic Markers Are Associated with Future Waist-Gaining Phenotype in WomenQ36056872
Cardiovascular Disease Mortality Among Breast Cancer SurvivorsQ36338451
Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancerQ36680439
Elevated asymmetric dimethylarginine in young adult survivors of childhood acute lymphoblastic leukemia: a preliminary reportQ37261768
Asymmetric dimethylarginine attenuates serum starvation-induced apoptosis via suppression of the Fas (APO-1/CD95)/JNK (SAPK) pathway.Q37299599
Defective adipose lipolysis and altered global energy metabolism in mice with adipose overexpression of the lipolytic inhibitor G0/G1 switch gene 2 (G0S2).Q37511665
Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity.Q37699221
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) studyQ37723285
A plasma metabolomic signature discloses human breast cancer.Q37746050
Sphingolipid metabolism and analysis in metabolic diseaseQ37930541
Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanismsQ37963505
Ceramide-orchestrated signalling in cancer cells.Q38067062
Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.Q38649483
Long-Term Cardiovascular Risk After Radiotherapy in Women With Breast CancerQ39321063
Taxane-based adjuvant chemotherapy reduces endothelin-1 and symmetric dimethylarginine levels in patients with breast cancerQ39828355
Obesity, adipokines, and C-peptide are associated with distinct plasma phospholipid profiles in adult males, an untargeted lipidomic approach.Q40109903
Inflammation-sensitive plasma proteins are associated with future weight gainQ40572272
Stimulation by de novo-synthesized ceramide of phospholipase A(2)-dependent cholesterol esterification promoted by the uptake of oxidized low-density lipoprotein in macrophages.Q40731446
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer ProgressionQ41045365
Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?Q41472829
An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapyQ41492616
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectlipoproteinQ28350
weight gainQ3403879
P304page(s)1144-1154
P577publication date2018-10-01
P1433published inBritish Journal of CancerQ326309
P1476titleMetabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
P478volume119